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Abstract
© 2017  Milošević,  Milicević,  Božić,  Lavrnja,  Stevanović,  Bijelić,  Dubaić,  Živković,  Stević,
Giniatullin and Andjus. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with
a very fast progression, no diagnostic tool for the presymptomatic phase, and still no effective
treatment of the disease. Although ALS affects motor neurons, the overall pathophysiological
condition points out to the non-cell autonomous mechanisms, where astrocytes and microglia
play crucial roles in the disease progression. We have already shown that IgG from sera of ALS
patients (ALS IgG) induce calcium transients and an increase in the mobility of acidic vesicles in
cultured rat astrocytes. Having in mind the role of microglia in neurodegeneration, and a well-
documented fact that oxidative stress is  one of  the many components contributing to the
disease,  we decided to examine the effect  of  ALS IgG on activation,  oxidative stress and
antioxidative system of BV-2 microglia, and to evaluate their acute effect on cytosolic peroxide,
pH, and on reactive oxygen species (ROS) generation. All tested ALS IgGs (compared to control
IgG) induced oxidative stress (rise in nitric oxide and the index of lipid peroxidation) followed by
release  of  TNF-α  and higher  antioxidative  defense  (elevation  of  Mn-  and CuZn-superoxide
dismutase, catalase, and glutathione reductase with a decrease of glutathione peroxidase and
glutathione) after 24 h treatment. Both ALS IgG and control IgG showed same localization on the
membrane of BV-2 cells following 24 h treatment. Cytosolic peroxide and pH alteration were
evaluated with fluorescent probes HyPer and SypHer, respectively, having in mind that HyPer
also reacts to pH changes. Out of 11 tested IgGs from ALS patients, 4 induced slow exponential
rise of HyPer signal, with maximal normalized fluorescence in the range 0.2-0.5, also inducing
similar increase of SypHer intensity, but of a lower amplitude. None of the control IgGs induced
changes with neither of the indicators. Acute ROS generation was detected in one out of three
tested  ALS  samples  with  carboxy-H2DCFDA.  The  observed  phenomena  demonstrate  the
potential role of inflammatory humoral factors, IgGs, as potential triggers of the activation in
microglia, known to occur in later stages of ALS. Therefore, revealing the ALS IgG signaling
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